Dr. Mark Filiaggi, Department of Applied Oral Sciences, along with co-investigators Dr. Bob Abraham and PhD student Arash Momeni, has been awarded $49,500 of Early Stage Commercialization Funding from Innovacorp for "Commercialization of CaP Liquid Embolic System."
This funding will help develop and commercialize a liquid embolic material. This new material is designed to be injected into blood vessels where it will form a solid or gel-like embolus (blockage).
Embolization is commonly used to stop uncontrolled bleeding or to block blood flow to a target tissue, such as a tumour. The researchers believe this new material will have several advantages over existing liquid embolics and intend to initially focus its use on the treatment of tumours.
Recent News
- Debby Chao receives the Dr. David Precious Gold Medal in Dentistry
- Impact Award winner 2021: Rebecca Marr
- One year later: Faculty of Dentistry dean on change, compassion, and lessons learned from COVID‑19
- Let's walk, run, and bicycle to the McGill Faculty of Dentistry
- RIOH Student Presentations Showcase: And the winners are. . .
- The Research In Oral Health Student Presentations Showcase – the new Table Clinics
- Doris Marshall (DDS’56): The Faculty of Dentistry’s first Black student
- Providing a path into health‑care professionals for African Nova Scotian students